Cas:1160994-94-4 Methyl 8-aminoimidazo[1,2-a]pyridine-6-carboxylate manufacturer & supplier

Chemical Name:Methyl 8-aminoimidazo[1,2-a]pyridine-6-carboxylate

CAS.NO:1160994-94-4

Synonyms:Imidazo[1,2-a]pyridine-6-carboxylic acid, 8-amino-, methyl ester;Methyl 8-aminoimidazo[1,2-a]pyridine-6-carboxylate

Molecular Formula:C₉H₉N₃O₂

Molecular Weight:191.187

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.4±0.1 g/cm3

Index of Refraction:1.657

PSA:69.62000

Exact Mass:191.069473

LogP:1.26

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Imidazo[1,2-a]pyridine-6-carboxylic acid, 8-amino-, methyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 8-aminoimidazo[1,2-a]pyridine-6-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Imidazo[1,2-a]pyridine-6-carboxylic acid, 8-amino-, methyl ester Use and application,Methyl 8-aminoimidazo[1,2-a]pyridine-6-carboxylate technical grade,usp/ep/jp grade.

Related News: Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). Methyl 8-aminoimidazo[1,2-a]pyridine-6-carboxylate manufacturer We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua��s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed. Methyl 8-aminoimidazo[1,2-a]pyridine-6-carboxylate supplier FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus. Methyl 8-aminoimidazo[1,2-a]pyridine-6-carboxylate vendor Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). Methyl 8-aminoimidazo[1,2-a]pyridine-6-carboxylate factory Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).